Cataya

Shanghai-based biotech company Cataya, which specializes in synthetic biology, has reportedly raised RMB 250 million (USD 35 million) in a Series B financing round. The round was co-led by Hengxu Capital and Eight Roads Ventures, with additional investments from Hui Rong Technology Service and Bits x Bites. Cataya’s DBTL Platform…